Controlled-release hydromorphone and risk of infection in adults: a systematic review

Controlled-release hydromorphone and risk of infection in adults: a systematic review

Abstract Background Preliminary evidence suggests that people who inject drugs (PWID) may be at an increased risk of developing infective endocarditis (IE), hepatitis C virus (HCV) infection, and/or human immunodeficiency virus (HIV) infection from hydromorphone controlled-release formulation. The h...

Full description

Bibliographic Details
Main Authors: Andrea C. Tricco, Amanda Parker, Areej Hezam, Vera Nincic, Fatemeh Yazdi, Yonda Lai, Charmalee Harris, Zachary Bouck, Ahmed M. Bayoumi, Sharon E. Straus
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Harm Reduction Journal
Subjects:
Controlled-release hydromorphone
Knowledge synthesis
Systematic review
Risk factor
HCV
HIV
Online Access:https://doi.org/10.1186/s12954-023-00788-9

Internet

https://doi.org/10.1186/s12954-023-00788-9

Similar Items